Clinical Trials Browser

Phase 1 × OTHER × Cytomegalovirus Infections × Clear all

NCT05101213 2025-10-14

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Phase 1 Recruiting

Other hematologic neoplasm

Adenoviridae Infections, Cytomegalovirus Infections, Hematologic Neoplasms

NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Phase 1 Recruiting

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

NCT05183490 2024-12-30

R-MVST Cells for Treatment of Viral Infections

Phase 1 Recruiting

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT05589844 2023-04-27

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Phase 1 Withdrawn

Cytomegalovirus Infections

NCT01535885 2021-10-25

ACE

Phase 1 Completed

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT02988258 2018-09-12

CMV_TCR-001

Phase 1 Suspended

Cytomegalovirus Infections

NCT01070797 2014-09-04

VIRAGE

Phase 1 Completed

Adenoviridae Infections, Cytomegalovirus Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT00712634 2009-12-21

Cytomegalovirus Vaccine in Healthy Participants

Phase 1 Completed

Cytomegalovirus Infections, Precancerous Conditions